Literature DB >> 20723550

The effect of chromium on rat insulinoma cells in high glucose conditions.

Min J Kwon1, Hye S Chung, Chang S Yoon, Jung H Ko, Hae J Jun, Tae K Kim, Soon H Lee, Kyung S Ko, Byung D Rhee, Mi K Kim, Jeong H Park.   

Abstract

AIMS: it has been suggested that Chromium (Cr), one of the essential minerals, can be beneficial to type 2 diabetic patients because it lowers blood glucose levels by improving various steps in insulin action. A few studies reported that Cr might also have some beneficial effects in people with type 1 diabetes mellitus and in streptozotocin-treated rats, but direct beneficial effects of Cr on pancreatic beta cells have not been proven. We performed this study to determine whether Cr could have direct protective effects on INS-1 cells in high glucose conditions that mimic the actual diabetic state. MAIN
METHODS: INS-1 cells were cultured for 48h in RPMI medium with 33mM glucose as the stress condition and 11mM glucose as a control. CrCl(3) was used to verify whether Cr could protect INS-1 cells from glucotoxic stress. Cell viability and apoptosis were evaluated by MTT assay and FACS. The level of insulin mRNA, by semi-quantitative RT-PCR, was significantly reduced at 33mM glucose concentration after 48h of incubation. KEY
FINDINGS: cell viability was reduced by 50%, and 35% of the cells underwent apoptosis at the same culture condition. Addition of various concentrations of CrCl(3) to INS-1 cells in 33mM glucose for different durations of time did not reveal any beneficial effects on cell viability, degree of apoptosis, insulin mRNA levels, and glucose stimulated insulin secretion. SIGNIFICANCE: we could not find any evidence that Cr had direct beneficial effects on INS-1 cells in high glucose induced stress conditions. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723550     DOI: 10.1016/j.lfs.2010.08.001

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Chromium picolinate and chromium histidinate protects against renal dysfunction by modulation of NF-κB pathway in high-fat diet fed and Streptozotocin-induced diabetic rats.

Authors:  Mustafa Yavuz Selcuk; Bilge Aygen; Ayhan Dogukan; Zeynep Tuzcu; Fatih Akdemir; James R Komorowski; Mustafa Atalay; Kazim Sahin
Journal:  Nutr Metab (Lond)       Date:  2012-04-08       Impact factor: 4.169

2.  Chromium level in prediction of diabetes in pre-diabetic patients.

Authors:  Rahmatollah Rafiei; Zahra Habyby; Lootfollah Fouladi; Somayeh Najafi; Sedigheh Asgary; Zahra Torabi
Journal:  Adv Biomed Res       Date:  2014-11-29

3.  A Comparative Study of Relationship between Micronutrients and Gestational Diabetes.

Authors:  Farideh Akhlaghi; Seyyed Majid Bagheri; Omid Rajabi
Journal:  ISRN Obstet Gynecol       Date:  2012-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.